Press release
Global Cancer Tissue Diagnostic Market Poised for Remarkable Growth with Projected Value of USD 23,516.2 million by 2034
Cancer Tissue Diagnostic Market
The surge in cancer cases across the globe is driving this growth, intensifying the demand for effective diagnostic tools. As healthcare providers strive to improve diagnostic accuracy, the role of cutting-edge technologies and methodologies has never been more critical. Early detection is key to improving patient outcomes, and advancements in diagnostic tools are helping healthcare professionals identify cancer more accurately and at earlier stages.
Explore Emerging Market Insights: Request a Sample Report Now! https://www.futuremarketinsights.com/reports/sample/rep-gb-4191
One key area fueling the expansion of the cancer tissue diagnostics market is the increasing prevalence of cancer, which has placed greater demand on diagnostic kits, particularly those used in clinical settings to process larger volumes of plasma and generate high concentrations of eluates. These developments not only enhance patient care but also create a strong foundation for market growth.
Leading companies in the cancer tissue diagnostics sector are prioritizing research and development, heavily investing in innovative product development. This focus on innovation is essential as the medical community continues to battle the challenges of cancer, including high false-positive rates and treatment uncertainties. By advancing their portfolios, these companies are strengthening their global presence and responding to the growing needs of healthcare systems.
Despite remarkable strides in detection and treatment, cancer remains the deadliest global illness. In response, medical professionals and researchers are actively exploring technologies, including artificial intelligence, to enhance cancer detection and treatment strategies further. The future of cancer diagnostics lies in harnessing these innovations to not only address current challenges but also to improve the accuracy and efficacy of treatments.
As the cancer tissue diagnostic market continues to evolve, stakeholders must remain committed to leveraging cutting-edge technology and innovation. By doing so, they can better address the pressing challenges in cancer diagnostics and ultimately improve patient care and outcomes on a global scale.
Key Takeaways from the Market Study:
• By product type, molecular diagnostic test kits held the highest share of 42.7% in 2023 in the market.
• In 2023, by cancer type, the breast cancer segment held a substantial share of 22.7%.
• The United States is expected to surge at a CAGR of 3.1% by 2034.
• China is projected to rise at 6.8% CAGR by 2034.
• Based on cancer type, the breast cancer segment is expected to rise at 5.1% CAGR by 2034.
"Private diagnostic centers worldwide are expanding due to rising demand for imaging and increasing workload on public hospitals. They are also working on liquid biopsy and animal cancer therapies, offering profitable growth prospects for global cancer diagnostic market,"- says Future Market Insights (FMI) lead analyst.
Rising Demand for Market Data: Our Full Report Offers Deep Insights and Trend Analysis! https://www.pharmiweb.com/press-release/2023-11-07/cancer-tissue-diagnostics-market-is-forecasted-to-achieve-a-valuation-of-us-13-219-million-by-2033
Competitive Landscape:
Expansion of product portfolios by launching technologically advanced products is a key strategy of the leading companies and manufacturers. Key companies focus on collaborations to compete with competitors in the market.
For instance,
• In March 2022, Thermo Fisher Scientific launched the CE-IVD-marked next-generation sequencing instrument for clinical labs.
• In March 2021, F. Hoffmann-La Roche Ltd. merged with GenMark Diagnostics, Inc., to access a novel technology for testing a wide range of pathogens with one patient sample.
Key Companies Profiled:
• Abbott Laboratories
• F.Hoffmann-La Roche Ltd.
• Thermo Fisher Scientific Inc.
• Merck KGaA (Sigma-Aldrich Co., LLC)
• Danaher Corporation (Cepheid)
• Agilent Technologies, Inc.
• Quest Diagnostics Incorporated
• Bio Rad Laboratories Inc.
• QIAGEN
• Illumina, Inc.
• Enzo Life Sciences, Inc.
• BioGenex
• Bio SB
• Nanoprobes, Inc.
• Creative Biolabs.
• Takara Bio Inc.
Cancer Tissue Diagnostics Industry Segmentation by Category:
By Product:
• In Situ Hybridization (ISH) Test Kits
o Fluorescent In Situ Hybridization (FISH) Kits
o Chromogenic In Situ Hybridization (CISH) Kits
• Molecular Diagnostics Test Kits
o Polymerase Chain Reaction (PCR) Kits
o Next-generation Sequencing (NGS) Kits
• Companion Diagnostics Test Kits
o Genetic Testing Kits
o Biomarker Testing Kits
• Immunohistochemistry (IHC) Test Kits
By Cancer:
• Breast Cancer
• Lung Cancer
• Colorectal Cancer
• Prostate Cancer
• Ovarian Cancer
• Hematologic Cancer
• Liver Cancer
• Pancreatic Cancer
• Skin Cancer (Melanoma)
• Others
By End-user:
• Hospitals
• Specialty Centers
• Long-term Care Centers
• Diagnostic Centers
• Academic & Research Institutes
By Region:
• North America
• Latin America
• East Asia
• South Asia & Pacific
• Western Europe
• Eastern Europe
• Middle East & Africa
𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐅𝐌𝐈'𝐬 𝐑𝐞𝐥𝐚𝐭𝐞𝐝 𝐎𝐧𝐠𝐨𝐢𝐧𝐠 𝐂𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐨𝐧 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝐌𝐚𝐫𝐤𝐞𝐭 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐃𝐨𝐦𝐚𝐢𝐧:
Transcutaneous Monitors Market https://www.fmiblog.com/2024/11/15/transcutaneous-monitors-market-demand/
Pedicle Screw Systems Market https://www.fmiblog.com/2024/11/15/global-pedicle-screw-system-market-projected-to-reach-usd-6-46-billion-by-2029-expanding-at-a-cagr-of-4-6/
Stool Management Systems Market https://www.fmiblog.com/2024/11/15/global-stool-management-system-market-projected-to-reach-usd-631-64-million-by-2034-exhibiting-a-sluggish-cagr-of-3-0/
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Cancer Tissue Diagnostic Market Poised for Remarkable Growth with Projected Value of USD 23,516.2 million by 2034 here
News-ID: 3791107 • Views: …
More Releases from Future Market Insights Inc
Endoscopy Fluid Management Systems Market Poised for Significant Growth, Project …
The global Endoscopy Fluid Management Systems Market is on a trajectory of significant expansion, with a new market forecast projecting its value to more than double over the next decade. According to the latest analysis, the market, valued at an estimated USD 550.3 million in 2025, is expected to surge to USD 1,123.7 million by 2035. This robust growth represents a compound annual growth rate (CAGR) of 7.4% and is…
NGS Sample Preparation Market Poised for Explosive Growth, Set to Triple by 2035 …
A new market analysis projects the global Next-Generation Sequencing (NGS) Sample Preparation market to experience a significant surge, forecasting a valuation of USD 7.0 billion by 2035. This marks a substantial increase from its estimated USD 1.9 billion value in 2025, reflecting a robust Compound Annual Growth Rate (CAGR) of 13.7% over the decade. The findings underscore the pivotal role of sample preparation in the expanding field of genomics, driven…
Eye and Face Protection Market USD 2.3 Billion by 2035 Key Players Medline Indus …
The global Eye and Face Protection Market is poised for significant expansion, with a new forecast predicting it will grow from an estimated USD 859.3 million in 2025 to USD 2,332.2 million by 2035. This robust growth trajectory represents a compound annual growth rate (CAGR) of 10.5% over the forecast period, driven by a confluence of rising industrial safety awareness, stringent regulatory mandates, and technological innovation.
Click Here for More Information:-…
Dermatology Excimer Lasers Market to Nearly Triple by 2035 Key Players Cutera, I …
The global market for dermatology excimer lasers is projected to surge from an estimated USD 109.7 million in 2025 to a remarkable USD 317.1 million by 2035, marking a significant compound annual growth rate (CAGR) of 11.2%. This substantial expansion is being fueled by a combination of factors, including the rising global prevalence of chronic skin conditions and a growing preference for advanced, targeted therapies.
Click Here for More Information:- https://www.futuremarketinsights.com/reports/dermatology-excimer-lasers-market
Dermatology…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
